• Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2017  |  Volume : 3  |  Issue : 3  |  Page : 80-86

Fish oil and prostate cancer: Effects and clinical relevance

Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA

Correspondence Address:
Dr. Pei Liang
Department of Urology, University of California, P.O. Box 951738, Los Angeles, CA 90095-1738
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ctm.ctm_63_16

Rights and Permissions

Men who intake high ratios of fish oil or omega-3 fatty acids (FAs), especially docosahexaenoic acid and eicosapentaenoic acid, relative to omega-6 arachidonic acid have been found to have a decreased risk of prostate cancer compared to those with low ratios in some but not all case-control and cohort studies. Primary prevention trials with either risk biomarkers or cancer incidence as endpoints regarding the association between omega-3 FA consumption and risk of prostate cancer are studded with controversial results. However, many clinical trials have shown that fish oil could decrease the risk of developing prostate cancer. The anticancer properties of anticancer drugs could be greatly improved when combined with fish oil. We briefly reviewed fish oil and relevant omega-3 FAs as well as early investigations in prostate cancer prevention and treatment.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded469    
    Comments [Add]    
    Cited by others 1    

Recommend this journal